Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0566 USD
−3.73 M USD
29.60 M USD
35.12 M
About Emmaus Life Sciences, Inc.
Sector
CEO
Willis C. Lee
Headquarters
Torrance
Website
Founded
1987
FIGI
BBG000BQC327
Emmaus Life Sciences, Inc. engages in the discovery, development, marketing, and sale of treatments and therapies for rare and orphan diseases. It operates through the Marketing and Sales of Endari segment. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EMMA is 0.0086 USD — it has increased by 41.41% in the past 24 hours. Watch Emmaus Life Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Emmaus Life Sciences, Inc. stocks are traded under the ticker EMMA.
EMMA stock has risen by 64.71% compared to the previous week, the month change is a −6.67% fall, over the last year Emmaus Life Sciences, Inc. has showed a −93.38% decrease.
EMMA reached its all-time high on Jan 3, 2008 with the price of 30,593.8800 USD, and its all-time low was 0.0001 USD and was reached on Aug 14, 2024. View more price dynamics on EMMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EMMA stock is 62.79% volatile and has beta coefficient of 173.48. Track Emmaus Life Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Emmaus Life Sciences, Inc. there?
Today Emmaus Life Sciences, Inc. has the market capitalization of 549.24 K, it has decreased by −19.29% over the last week.
Yes, you can track Emmaus Life Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
Emmaus Life Sciences, Inc. is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
EMMA net income for the last quarter is 1.83 M USD, while the quarter before that showed −2.18 M USD of net income which accounts for 183.65% change. Track more Emmaus Life Sciences, Inc. financial stats to get the full picture.
No, EMMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 15, 2025, the company has 55.00 employees. See our rating of the largest employees — is Emmaus Life Sciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Emmaus Life Sciences, Inc. EBITDA is 41.00 K USD, and current EBITDA margin is 12.07%. See more stats in Emmaus Life Sciences, Inc. financial statements.
Like other stocks, EMMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Emmaus Life Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Emmaus Life Sciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Emmaus Life Sciences, Inc. stock shows the sell signal. See more of Emmaus Life Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.